Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 191

1.

Restless legs syndrome outside the blood-brain barrier--exacerbation by domperidone in Parkinson's disease.

Rios Romenets S, Dauvilliers Y, Cochen De Cock V, Carlander B, Bayard S, Galatas C, Wolfson C, Postuma RB.

Parkinsonism Relat Disord. 2013 Jan;19(1):92-4. doi: 10.1016/j.parkreldis.2012.07.019. Epub 2012 Aug 24.

PMID:
22922159
2.

Restless legs syndrome in Korean patients with drug-naïve Parkinson's disease: a nation-wide study.

Shin HY, Youn J, Yoon WT, Kim JS, Cho JW.

Parkinsonism Relat Disord. 2013 Mar;19(3):355-8. doi: 10.1016/j.parkreldis.2012.09.009. Epub 2012 Oct 6.

PMID:
23047004
3.

Restless legs syndrome and Parkinson's disease: insights into pathophysiology.

Lang AE.

Clin Neuropharmacol. 1987 Oct;10(5):476-8. No abstract available.

PMID:
3503686
4.

Restless legs syndrome in Parkinson's disease.

Tan EK, Lum SY, Wong MC.

J Neurol Sci. 2002 Apr 15;196(1-2):33-6.

PMID:
11959153
5.

Restless legs syndrome in Parkinson's disease: clinical characteristics and biochemical correlations.

Guerreiro TM, Nishikawa DR, Ferreira LC, Melo HA, Prado RC.

Arq Neuropsiquiatr. 2010 Dec;68(6):869-72.

6.

Spinal cord mechanisms in amitriptyline responsive restless legs syndrome in Parkinson's disease.

Sandyk R, Iacono RP, Bamford CR.

Int J Neurosci. 1988 Jan;38(1-2):121-4.

PMID:
3356496
7.

[Dopamine dysregulation syndrome in Parkinson's disease and restless legs syndrome].

Bayard S, Cochen De Cock V, Dauvillers Y.

Geriatr Psychol Neuropsychiatr Vieil. 2011 Jun;9(2):227-35. doi: 10.1684/pnv.2011.0275. Review. French.

PMID:
21690031
8.

[Sleep disorders in Parkinson's disease: REM sleep behaviour disorder and restless legs syndrome].

Jáuregui-Barrutia A, Tijero-Merino B, Gómez-Esteban JC, Zarranz JJ.

Rev Neurol. 2010 Feb 8;50 Suppl 2:S15-9. Review. Spanish.

9.

Clinical characteristics of Restless legs syndrome in patients with Parkinson's disease.

Nomura T, Inoue Y, Nakashima K.

J Neurol Sci. 2006 Dec 1;250(1-2):39-44. Epub 2006 Aug 8.

PMID:
16899256
10.

Severe restless legs syndrome presenting as intractable insomnia.

Arnulf I, Konofal E, Gauthier C, Chedru F.

Neurology. 2004 Apr 27;62(8):E19. No abstract available.

PMID:
15111708
11.

Restless legs syndrome in Parkinson's disease: a case-controlled study.

Krishnan PR, Bhatia M, Behari M.

Mov Disord. 2003 Feb;18(2):181-5.

PMID:
12539212
12.

Domperidone in Parkinson's disease: a perilous arrhythmogenic or the gold standard?

Lertxundi U, Domingo-Echaburu S, Soraluce A, García M, Ruiz-Osante B, Aguirre C.

Curr Drug Saf. 2013 Feb;8(1):63-8.

PMID:
23656449
13.

The low prevalence of primary restless legs syndrome in Thai Parkinson's disease patients at Chulalongkorn University Hospital.

Jagota P, Asawavichienjinda T, Bhidayasiri R.

J Med Assoc Thai. 2012 Feb;95(2):175-80.

PMID:
22435246
14.

Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome.

Reuter I, Ellis CM, Ray Chaudhuri K.

Acta Neurol Scand. 1999 Sep;100(3):163-7.

PMID:
10478579
15.

Restless legs syndrome in Parkinson's disease.

Peralta CM, Frauscher B, Seppi K, Wolf E, Wenning GK, Högl B, Poewe W.

Mov Disord. 2009 Oct 30;24(14):2076-80. doi: 10.1002/mds.22694.

PMID:
19691124
16.

Restless legs symptoms in a patient with above knee amputations: a case of phantom restless legs.

Hanna PA, Kumar S, Walters AS.

Clin Neuropharmacol. 2004 Mar-Apr;27(2):87-9.

PMID:
15252270
17.

Association of restless legs syndrome, pain, and mood disorders in Parkinson's disease.

Rana AQ, Qureshi AR, Rahman L, Jesudasan A, Hafez KK, Rana MA.

Int J Neurosci. 2016;126(2):116-20. doi: 10.3109/00207454.2014.994208. Epub 2015 May 22.

PMID:
25469455
18.

Frequency of impulse control behaviours associated with dopaminergic therapy in restless legs syndrome.

Voon V, Schoerling A, Wenzel S, Ekanayake V, Reiff J, Trenkwalder C, Sixel-Döring F.

BMC Neurol. 2011 Sep 28;11:117. doi: 10.1186/1471-2377-11-117.

19.

Restless legs syndrome in Parkinson's disease and other neurodegenerative diseases of the central nervous system.

Iranzo A, Comella CL, Santamaria J, Oertel W.

Mov Disord. 2007;22 Suppl 18:S424-30. Review. Erratum in: Mov Disord. 2008 Jun;23(8):1200-2.

PMID:
17534950
20.

Quick titration of pergolide in cotreatment with domperidone is safe and effective.

Jansen PA, Herings RM, Samson MM, De Vreede PL, Schuurmans-Daemen LM, Hovestadt A, Verhaar HJ, Van Laar T.

Clin Neuropharmacol. 2001 May-Jun;24(3):177-80.

PMID:
11391131

Supplemental Content

Support Center